Stahel RA - Search Results

1

Functional Genomic Screen in Mesothelioma Reveals that Loss of Function of BRCA1-Associated Protein 1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition.

Okonska A, Bühler S, Rao V, Ronner M, Blijlevens M, van der Meulen-Muileman IH, de Menezes RX, Wipplinger M, Oehl K, Smit EF, Weder W, Stahel RA, Penengo L, van Beusechem VW, Felley-Bosco E. Okonska A, et al. Among authors: stahel ra. Mol Cancer Ther. 2020 Feb;19(2):552-563. doi: 10.1158/1535-7163.MCT-19-0356. Epub 2019 Oct 16. Mol Cancer Ther. 2020. PMID: 31619462

2

Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress.

Kotov IN, Siebring-van Olst E, Knobel PA, van der Meulen-Muileman IH, Felley-Bosco E, van Beusechem VW, Smit EF, Stahel RA, Marti TM. Kotov IN, et al. Among authors: stahel ra. Mol Oncol. 2014 Dec;8(8):1747-59. doi: 10.1016/j.molonc.2014.07.008. Epub 2014 Jul 22. Mol Oncol. 2014. PMID: 25113059 Free PMC article.

3

Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases.

Rusch A, Ziltener G, Nackaerts K, Weder W, Stahel RA, Felley-Bosco E. Rusch A, et al. Among authors: stahel ra. Lung Cancer. 2015 Jan;87(1):77-9. doi: 10.1016/j.lungcan.2014.10.017. Epub 2014 Nov 6. Lung Cancer. 2015. PMID: 25468148 Free article.

4

A Novel BRCA1-Associated Protein-1 Isoform Affects Response of Mesothelioma Cells to Drugs Impairing BRCA1-Mediated DNA Repair.

Parrotta R, Okonska A, Ronner M, Weder W, Stahel R, Penengo L, Felley-Bosco E. Parrotta R, et al. J Thorac Oncol. 2017 Aug;12(8):1309-1319. doi: 10.1016/j.jtho.2017.03.023. Epub 2017 Apr 4. J Thorac Oncol. 2017. PMID: 28389374 Free article.

5

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.

Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, Stahel RA. Belyanskaya LL, et al. Among authors: stahel ra. Mol Cancer. 2007 Oct 22;6:66. doi: 10.1186/1476-4598-6-66. Mol Cancer. 2007. PMID: 17953743 Free PMC article.

6

Malignant pleural mesothelioma.

Stahel RA, Felley-Bosco E, Opitz I, Weder W. Stahel RA, et al. Future Oncol. 2009 Apr;5(3):391-402. doi: 10.2217/fon.09.7. Future Oncol. 2009. PMID: 19374545 Review.

7

Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?

Stahel RA, Weder W. Stahel RA, et al. Curr Opin Oncol. 2009 Mar;21(2):124-30. doi: 10.1097/CCO.0b013e328324bc30. Curr Opin Oncol. 2009. PMID: 19532013 Review.

8

Role of hedgehog signaling in malignant pleural mesothelioma.

Shi Y, Moura U, Opitz I, Soltermann A, Rehrauer H, Thies S, Weder W, Stahel RA, Felley-Bosco E. Shi Y, et al. Among authors: stahel ra. Clin Cancer Res. 2012 Sep 1;18(17):4646-56. doi: 10.1158/1078-0432.CCR-12-0599. Epub 2012 Jun 25. Clin Cancer Res. 2012. PMID: 22733539 Free article.

9

GAS5 long non-coding RNA in malignant pleural mesothelioma.

Renganathan A, Kresoja-Rakic J, Echeverry N, Ziltener G, Vrugt B, Opitz I, Stahel RA, Felley-Bosco E. Renganathan A, et al. Among authors: stahel ra. Mol Cancer. 2014 May 23;13:119. doi: 10.1186/1476-4598-13-119. Mol Cancer. 2014. PMID: 24885398 Free PMC article.

10

Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.

Meerang M, Bérard K, Felley-Bosco E, Lauk O, Vrugt B, Boss A, Kenkel D, Broggini-Tenzer A, Stahel RA, Arni S, Weder W, Opitz I. Meerang M, et al. Among authors: stahel ra. Mol Cancer Ther. 2016 May;15(5):1095-105. doi: 10.1158/1535-7163.MCT-15-0583. Epub 2016 Feb 2. Mol Cancer Ther. 2016. PMID: 26839306 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

416 results

Search Page